INDRAMEDCO shows sign of weakness as investors do cost averaging
08 Sep, 20255 min read
INDRAMEDCO managed to outperform the broader market today. On a longer term basis, investors in INDRAPRASTHA MEDICAL CORP made +0.03% per day. Monday's performance of -1.13% was a underperformance compared to it's daily average.